CA2109088A1 - Methode de detection et de traitement de maladies causees par des allergenes bacteriens - Google Patents

Methode de detection et de traitement de maladies causees par des allergenes bacteriens

Info

Publication number
CA2109088A1
CA2109088A1 CA002109088A CA2109088A CA2109088A1 CA 2109088 A1 CA2109088 A1 CA 2109088A1 CA 002109088 A CA002109088 A CA 002109088A CA 2109088 A CA2109088 A CA 2109088A CA 2109088 A1 CA2109088 A1 CA 2109088A1
Authority
CA
Canada
Prior art keywords
composition
allergen
protein
comprised
pylori
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002109088A
Other languages
English (en)
Inventor
Emanuel Calenoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2109088A1 publication Critical patent/CA2109088A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002109088A 1991-04-26 1992-04-21 Methode de detection et de traitement de maladies causees par des allergenes bacteriens Abandoned CA2109088A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69323291A 1991-04-26 1991-04-26
US693,232 1991-04-26

Publications (1)

Publication Number Publication Date
CA2109088A1 true CA2109088A1 (fr) 1992-10-27

Family

ID=24783856

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002109088A Abandoned CA2109088A1 (fr) 1991-04-26 1992-04-21 Methode de detection et de traitement de maladies causees par des allergenes bacteriens

Country Status (4)

Country Link
EP (1) EP0582672A4 (fr)
JP (1) JPH06507494A (fr)
CA (1) CA2109088A1 (fr)
WO (1) WO1992019970A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5972336A (en) * 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
EP0705426A4 (fr) * 1993-06-09 1998-07-08 Quidel Corp Titrages en une etape specifiques d'un antigene
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
KR100333113B1 (ko) * 1993-07-27 2002-11-27 시에스엘 리미티드 헬리코박터피롤리관련위십이지장질환의치료방법
WO1996012965A1 (fr) * 1994-10-20 1996-05-02 Genelabs Diagnostics Pte Ltd. Methodes de diagnostic de l'helicobacter pylori et necessaires correspondants
AU5523196A (en) * 1995-02-27 1996-09-18 Enteron Limited Partnership Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms
WO1997011368A1 (fr) * 1995-09-22 1997-03-27 Asahi Denka Kogyo K.K. Procede d'analyse pour allergene
EP1872792A1 (fr) * 2006-06-29 2008-01-02 Biotech Tools S.A. Méthode pour la production d'un allergène hydrolysé
WO2011098569A1 (fr) * 2010-02-12 2011-08-18 Laboratorios Leti, S.L. Unipersonal Procédé de fabrication d'un extrait d'allergènes
RU2568242C2 (ru) * 2012-04-24 2015-11-10 Федеральное государственное бюджетное учреждение науки Институт молекулярной биологии им В.А. Энгельгарда Российской академии наук (ИМБ РАН) Способ обработки образца крови при проведении иммунологического анализа аллерген-специфических и общих иммуноглобулинов е
RU2587327C2 (ru) * 2014-11-19 2016-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздрава России) Способ диагностики in vitro специфической сенсибилизации организма к бактериальным аллергенам

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5328989B2 (fr) * 1974-05-27 1978-08-17
US4870053A (en) * 1980-09-19 1989-09-26 Roussel Uclaf Novel compositions and processes
US4849337A (en) * 1983-01-31 1989-07-18 Minnesota Mining And Manufacturing Company Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
DE3708198A1 (de) * 1987-03-13 1988-09-22 Hoechst Ag Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
US5091318A (en) * 1990-04-13 1992-02-25 Abbott Laboratories Binding of allergens to a solid phase

Also Published As

Publication number Publication date
AU667040B2 (en) 1996-03-07
EP0582672A4 (en) 1994-06-29
AU2003692A (en) 1992-12-21
WO1992019970A1 (fr) 1992-11-12
JPH06507494A (ja) 1994-08-25
EP0582672A1 (fr) 1994-02-16

Similar Documents

Publication Publication Date Title
Deplazes et al. An enzyme-linked immunosorbent assay for diagnostic detection of Taenia saginata copro-antigens in humans
CN105461805B (zh) 抗猪流行性腹泻病毒单克隆抗体及其应用
CA2179153A1 (fr) Methodes et preparations pour le diagnostic et le traitement d'affections dues aux antigenes de micro-organismes
JPH10502366A (ja) ヘリコバクター・ピロリ抗原タンパク質調製品およびイムノアッセイ
JPH09502162A (ja) 三日熱マラリア原虫血液段階抗原、抗体、および診断用分析法
CA2109088A1 (fr) Methode de detection et de traitement de maladies causees par des allergenes bacteriens
CA2096016A1 (fr) Essais diagnostiques a l'aide d'antigenes pour infections par campylobacter jejuni ou coli
CN109387627A (zh) 一种基于胎盘样硫酸软骨素a的癌症筛查和早期诊断的试剂方法
WO2021233885A1 (fr) Peptides mimotopes de la protéine spike du virus sars-cov-2
US6830896B2 (en) Process for analyzing annexin-V in urine, and application thereof
Saito et al. Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury
EP0386166B1 (fr) ANTICORPS IgM REAGISSANT A LA PROTAMINE
JP3767755B2 (ja) 抗ｊｃウイルス抗体
KR101263913B1 (ko) 우결핵 진단 키트 및 이를 이용한 우결핵 진단 방법
CN110183530A (zh) 瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用
EP1765867B1 (fr) Anticorps monoclonaux anti-vih-1 vpr et methodes d'utilisation desdits anticorps
US7244580B2 (en) Epsilon immunoglobulin chain derived peptides for induction of anti-IgE antibodies
US20050100979A1 (en) Methods for detecting oxidative stress
KR102202082B1 (ko) 치쿤군야 바이러스의 외피단백질 도메인 ⅱ에 대해 특이적으로 결합하는 단일클론항체, 이를 생산하는 하이브리도마 세포주 및 이의 용도
KR920010224B1 (ko) 응집반응 측정법
JP3451783B2 (ja) コリンエステラーゼの測定法及び肝硬変と肝炎の識別法
KR102168417B1 (ko) 디프테리아 독소에 대해 특이적으로 결합하는 단일클론항체, 이를 생산하는 하이브리도마 세포주 및 이의 용도
JP4763149B2 (ja) ヘリコバクター・ピロリへの感染を判定する検査方法
WO1986003498A1 (fr) Anticorps monoclonaux et leur utilisation
KR20220122467A (ko) 사스-코로나바이러스-2에 특이적으로 결합하는 항체 및 그의 용도

Legal Events

Date Code Title Description
FZDE Dead